Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines.

Toshihiro Murata, Minoru Haisa, Hirokazu Uetsuka, Tetuji Nobuhisa, Takaomi Ookawa, Yoko Tabuchi, Yasuaki Shirakawa, Tomoki Yamatsuji, Junji Matsuoka, Masahiko Nishiyama, Noriaki Tanaka, Yoshio Naomoto

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

It is important to clarify the mechanism of resistance to cisplatin for the treatment of solid tumors. We have examined the expression of apoptosis-related proteins, Bax and Bcl-2, in ovarian cancer cells. We used the cell line 2008 and its cisplatin resistant subclone 2008 C-13. The percentage of 2008 cells showing apoptosis was significantly higher following cisplatin treatment as compared to untreated controls. 2008 C-13 cells showing apoptosis did not differ between the cisplatin-treated group and the untreated group. The expression of mRNA and protein of Bax in the two cell lines were not altered by treatment with cisplatin. Although the expression of mRNA and protein of Bcl-2 decreased in 2008 cells after treatment with cisplatin, the expression of Bcl-2 remained unchanged in 2008 C-13 cells. Our results indicate that the down-regulation of Bcl-2 plays an important role in the mechanisms of tumor resistance to anticancer drugs.

Original languageEnglish
Pages (from-to)865-868
Number of pages4
JournalInternational Journal of Molecular Medicine
Volume13
Issue number6
Publication statusPublished - Jun 2004

Fingerprint

Ovarian Neoplasms
Cisplatin
Cell Line
bcl-2-Associated X Protein
Apoptosis
Messenger RNA
Neoplasms
Down-Regulation
Pharmaceutical Preparations
Proteins

ASJC Scopus subject areas

  • Genetics

Cite this

Murata, T., Haisa, M., Uetsuka, H., Nobuhisa, T., Ookawa, T., Tabuchi, Y., ... Naomoto, Y. (2004). Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines. International Journal of Molecular Medicine, 13(6), 865-868.

Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines. / Murata, Toshihiro; Haisa, Minoru; Uetsuka, Hirokazu; Nobuhisa, Tetuji; Ookawa, Takaomi; Tabuchi, Yoko; Shirakawa, Yasuaki; Yamatsuji, Tomoki; Matsuoka, Junji; Nishiyama, Masahiko; Tanaka, Noriaki; Naomoto, Yoshio.

In: International Journal of Molecular Medicine, Vol. 13, No. 6, 06.2004, p. 865-868.

Research output: Contribution to journalArticle

Murata, T, Haisa, M, Uetsuka, H, Nobuhisa, T, Ookawa, T, Tabuchi, Y, Shirakawa, Y, Yamatsuji, T, Matsuoka, J, Nishiyama, M, Tanaka, N & Naomoto, Y 2004, 'Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines.', International Journal of Molecular Medicine, vol. 13, no. 6, pp. 865-868.
Murata T, Haisa M, Uetsuka H, Nobuhisa T, Ookawa T, Tabuchi Y et al. Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines. International Journal of Molecular Medicine. 2004 Jun;13(6):865-868.
Murata, Toshihiro ; Haisa, Minoru ; Uetsuka, Hirokazu ; Nobuhisa, Tetuji ; Ookawa, Takaomi ; Tabuchi, Yoko ; Shirakawa, Yasuaki ; Yamatsuji, Tomoki ; Matsuoka, Junji ; Nishiyama, Masahiko ; Tanaka, Noriaki ; Naomoto, Yoshio. / Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines. In: International Journal of Molecular Medicine. 2004 ; Vol. 13, No. 6. pp. 865-868.
@article{416feccdfd3d4d179b3da1807eafd0a5,
title = "Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines.",
abstract = "It is important to clarify the mechanism of resistance to cisplatin for the treatment of solid tumors. We have examined the expression of apoptosis-related proteins, Bax and Bcl-2, in ovarian cancer cells. We used the cell line 2008 and its cisplatin resistant subclone 2008 C-13. The percentage of 2008 cells showing apoptosis was significantly higher following cisplatin treatment as compared to untreated controls. 2008 C-13 cells showing apoptosis did not differ between the cisplatin-treated group and the untreated group. The expression of mRNA and protein of Bax in the two cell lines were not altered by treatment with cisplatin. Although the expression of mRNA and protein of Bcl-2 decreased in 2008 cells after treatment with cisplatin, the expression of Bcl-2 remained unchanged in 2008 C-13 cells. Our results indicate that the down-regulation of Bcl-2 plays an important role in the mechanisms of tumor resistance to anticancer drugs.",
author = "Toshihiro Murata and Minoru Haisa and Hirokazu Uetsuka and Tetuji Nobuhisa and Takaomi Ookawa and Yoko Tabuchi and Yasuaki Shirakawa and Tomoki Yamatsuji and Junji Matsuoka and Masahiko Nishiyama and Noriaki Tanaka and Yoshio Naomoto",
year = "2004",
month = "6",
language = "English",
volume = "13",
pages = "865--868",
journal = "International Journal of Molecular Medicine",
issn = "1107-3756",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines.

AU - Murata, Toshihiro

AU - Haisa, Minoru

AU - Uetsuka, Hirokazu

AU - Nobuhisa, Tetuji

AU - Ookawa, Takaomi

AU - Tabuchi, Yoko

AU - Shirakawa, Yasuaki

AU - Yamatsuji, Tomoki

AU - Matsuoka, Junji

AU - Nishiyama, Masahiko

AU - Tanaka, Noriaki

AU - Naomoto, Yoshio

PY - 2004/6

Y1 - 2004/6

N2 - It is important to clarify the mechanism of resistance to cisplatin for the treatment of solid tumors. We have examined the expression of apoptosis-related proteins, Bax and Bcl-2, in ovarian cancer cells. We used the cell line 2008 and its cisplatin resistant subclone 2008 C-13. The percentage of 2008 cells showing apoptosis was significantly higher following cisplatin treatment as compared to untreated controls. 2008 C-13 cells showing apoptosis did not differ between the cisplatin-treated group and the untreated group. The expression of mRNA and protein of Bax in the two cell lines were not altered by treatment with cisplatin. Although the expression of mRNA and protein of Bcl-2 decreased in 2008 cells after treatment with cisplatin, the expression of Bcl-2 remained unchanged in 2008 C-13 cells. Our results indicate that the down-regulation of Bcl-2 plays an important role in the mechanisms of tumor resistance to anticancer drugs.

AB - It is important to clarify the mechanism of resistance to cisplatin for the treatment of solid tumors. We have examined the expression of apoptosis-related proteins, Bax and Bcl-2, in ovarian cancer cells. We used the cell line 2008 and its cisplatin resistant subclone 2008 C-13. The percentage of 2008 cells showing apoptosis was significantly higher following cisplatin treatment as compared to untreated controls. 2008 C-13 cells showing apoptosis did not differ between the cisplatin-treated group and the untreated group. The expression of mRNA and protein of Bax in the two cell lines were not altered by treatment with cisplatin. Although the expression of mRNA and protein of Bcl-2 decreased in 2008 cells after treatment with cisplatin, the expression of Bcl-2 remained unchanged in 2008 C-13 cells. Our results indicate that the down-regulation of Bcl-2 plays an important role in the mechanisms of tumor resistance to anticancer drugs.

UR - http://www.scopus.com/inward/record.url?scp=4544263294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544263294&partnerID=8YFLogxK

M3 - Article

C2 - 15138626

AN - SCOPUS:4544263294

VL - 13

SP - 865

EP - 868

JO - International Journal of Molecular Medicine

JF - International Journal of Molecular Medicine

SN - 1107-3756

IS - 6

ER -